Alterations of pituitary-gonadal function in the carcinoid syndrome.
D000368:Aged; D001984:Bronchial Neoplasms / Q000503:physiopathology*; D002276:Carcinoid Tumor / Q000150:complications / Q000503:physiopathology*; D003533:Cyproheptadine / Q000494:pharmacology; D007172:Erectile Dysfunction / Q000209:etiology; D005260:Female; D005836:Genitalia, Female / Q000503:physiopathology*; D005837:Genitalia, Male / Q000503:physiopathology*; D006801:Humans; D007414:Intestinal Neoplasms / Q000503:physiopathology*; D007980:Levodopa / Q000494:pharmacology; D007989:Libido; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000150:complications / Q000503:physiopathology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010902:Pituitary Gland / Q000503:physiopathology*; D012701:Serotonin / Q000378:metabolism; D013739:Testosterone / Q000097:blood
D003533:Cyproheptadine; D012701:Serotonin; D013739:Testosterone; D007980:Levodopa; D007986:Luteinizing Hormone